APRE - CIK 0001781983
The table below shows Aprea Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $46.47M | $13.72M | $16.53M | $19.28M | $26.25M | $28.69M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $47.25M |
| $13.94M |
| $16.93M |
| $19.83M |
| $26.48M |
| $29.56M |
| Property, plant & equipment | $54.38K | $65.24K | $70.67K | $76.09K | $86.95K | $92.38K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $47.61M | $14.32M | $17.31M | $20.22M | $26.89M | $29.96M |
| Accounts payable | $2.94M | $641.32K | $1.20M | $1.28M | $1.15M | $964.33K |
| Total current liabilities | $5.30M | $2.68M | $3.17M | $3.36M | $3.64M | $3.09M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$336.93M | -$331.19M | -$328.21M | -$324.97M | -$318.15M | -$314.36M |
| Total equity | $41.59M | $10.91M | $13.41M | $15.55M | $21.95M | $25.56M |